Pendal Group Ltd trimmed its position in shares of Johnson & Johnson (NYSE:JNJ – Get Rating) by 47.6% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 61,292 shares of the company’s stock after selling 55,713 shares during the […]